1. Uncovering the roles of dihydropyrimidine dehydrogenase in fatty-acid induced steatosis using human cellular models.
- Author
-
Sullivan, Kelly E., Kumar, Sheetal, Liu, Xin, Zhang, Ye, de Koning, Emily, Li, Yanfei, Yuan, Jing, and Fan, Fan
- Subjects
FATTY degeneration ,FATTY liver ,METABOLIC regulation ,GAIN-of-function mutations ,DIHYDROPYRIMIDINE dehydrogenase ,GENETIC variation ,GLUCOSE-6-phosphate dehydrogenase - Abstract
Pyrimidine catabolism is implicated in hepatic steatosis. Dihydropyrimidine dehydrogenase (DPYD) is an enzyme responsible for uracil and thymine catabolism, and DPYD human genetic variability affects clinically observed toxicity following 5-Fluorouracil administration. In an in vitro model of fatty acid-induced steatosis, the pharmacologic inhibition of DPYD resulted in protection from lipid accumulation. Additionally, a gain-of-function mutation of DPYD, created through clustered regularly interspaced short palindromic repeats associated protein 9 (CRISPR-Cas9) engineering, led to an increased lipid burden, which was associated with altered mitochondrial functionality in a hepatocarcionma cell line. The studies presented herein describe a novel role for DPYD in hepatocyte metabolic regulation as a modulator of hepatic steatosis. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF